L-DOPA (L-3,4-dihydroxyphenylalanine) uptake by human red blood cells

Biochim Biophys Acta. 1981 Jul 20;645(2):165-9. doi: 10.1016/0005-2736(81)90186-3.

Abstract

The uptake of L-DOPA (L-3,4-dihydroxyphenylalanine) was studied in normal human red blood cells in vitro using L-[3-14C]DOPA. Uptake was slow, tending towards a distribution ratio close to unity with a half-time to equilibrium of one hour. Uptake was not Na+-dependent. Concentration dependence studies showed both saturable and non-saturable components of uptake, and inhibition studies using L-leucine and L-tryptophan suggest that the L and T systems of red cell amino acid uptake are involved. A powerful inhibitor of both systems, 3,4-dihydroxy-2-methylpropriophenone (U-0521), is described. It is concluded that uptake is by carrier-mediated facilitated diffusion via the L and T systems for which L-DOPA has low affinity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Biological Transport / drug effects
  • Cell Membrane Permeability
  • Erythrocytes / metabolism*
  • Humans
  • In Vitro Techniques
  • Kinetics
  • Leucine / pharmacology
  • Levodopa / blood*
  • Tryptophan / pharmacology

Substances

  • Levodopa
  • Tryptophan
  • Leucine